| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.96B | +0.1% |
| Cost of Revenue | $1.20B | +0.4% |
| R&D Expense | $183.0M | +4.6% |
| SG&A Expense | $690.1M | -6.2% |
| Operating Income | $826.4M | +1.1% |
| Interest Expense | $89.7M | -9.3% |
| Pre-tax Income | $754.9M | +2.5% |
| Income Tax | $117.0M | +24.5% |
| Net Income | $637.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $324.4M | -17.9% |
| Short-term Investments | $934K | +4.0% |
| Accounts Receivable | $733.4M | +4.4% |
| Inventory | $477.3M | -7.5% |
| Current Assets | $1.67B | -4.8% |
| Total Assets | $4.55B | -1.6% |
| Current Liabilities | $789.8M | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $762.1M | +26.4% |
| Investing Cash Flow | -$144.0M | +90.0% |
| Financing Cash Flow | -$696.7M | -192.3% |
| -0.7% |
| EPS (Basic) | $10.75 | -1.1% |
| EPS (Diluted) | $10.71 | -1.2% |
| Long-term Debt |
| $1.63B |
| -30.9% |
| Total Liabilities | $2.73B | -21.6% |
| Stockholders' Equity | $1.83B | +59.0% |